Understanding the impact of sex and stage differences on melanoma cancer patient survival: a SEER-based study.

ABSTRACT:

Background

This paper investigates the difference in survival of melanoma patients across stage and sex by utilising net survival measures. Metrics are presented at both the individual and population level.

Methods

Flexible parametric models were fitted to estimate life-expectancy metrics to be applied to a group of 104,938 subjects with a melanoma skin cancer diagnosis from 2000 to 2017. Period analysis was used for better predictions for newly diagnosed patients, and missing-stage information was imputed for 9918 patients. Female relative survival was assigned to male subjects to demonstrate the survival discrepancies experienced between sexes.

Results

At the age of 60, males diagnosed at the regional stage lose an average of 4.99 years of life compared to the gener

SUBMITTER: Smith AJ 

PROVIDER: S-EPMC7851379 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature